Composition
- Active ingredients
- BACITRACIN ZINC 400 UNITS/GM; HYDROCORTISONE ACETATE 1%; NEOMYCIN SULFATE EQ 3.5MG BASE/GM; POLYMYXIN B SULFATE 10,000 UNITS/GM
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application ANDA062166.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Bacitracin-Neomycin-Polymyxin W/ Hydrocortisone Acetate
- Active substance
- bacitracin zinc
- Route
- Eye
- Dosage form
- Ointment
- Applicant
- Padagis US
- Status
- Discontinued
- FDA approval
- 14 Apr 1981
- Application
- ANDA062166-002